NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies shareholders of Tenax Therapeutics, Inc. (NASDAQ:TENX) that a securities class action is pending on behalf of investors who purchased
SAN DIEGO, Nov. 9, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tenax Therapeutics, Inc. (NASDAQ:TENX) securities between November 13, 2023 and
Suit alleges Tenax Therapeutics, Inc. failed to disclose key facts to investors from November 13, 2023 through August 7, 2026; lead plaintiff deadline is December 28, 2026BENSALEM TOWNSHIP, Pa., Nov. 9, 2026
The DJS Law Group reminds investors of a class action lawsuit against Tenax Therapeutics, Inc. ("Tenax" or "the Company") (NASDAQ: TENX) for violations of §§10(b) and 20(a) of the Securities Exchange Act
ATLANTA, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Tenax Therapeutics, Inc. (TENX)
New York, New York--(Newsfile Corp. - November 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ:TENX) between November 13, 2023 and
NEW YORK, Nov. 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ:TENX) between November 13, 2023 and August 7,
New York, New York--(Newsfile Corp. - November 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ:TENX) between November 13, 2023 and
NEW YORK, Nov. 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Tenax Therapeutics, Inc. ("Tenax" or "the Company") (NASDAQ: TENX) for violations of §§10(b)
LOS ANGELES, Nov. 6, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tenax
Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tenax Therapeutics, Inc. ("Tenax" or "the Company")
SAN DIEGO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder-rights law firm, announces that a securities class action lawsuit has been filed in the United States District Court for the Middle
Lawsuit alleges Tenax Therapeutics, Inc. made misleading statements to investors from November 13, 2023 to August 7, 2026; lead plaintiff motions are due December 28, 2026LOS ANGELES, Nov. 6, 2026 /PRNewswire/ -- The
NEW YORK CITY, NY / ACCESS Newswire / November 6, 2026 / Levi & Korsinsky, LLP alerts investors in Tenax Therapeutics, Inc. (NASDAQ:TENX) that a pending securities class action names the Company's CEO and three
New York, New York--(Newsfile Corp. - November 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company")
